Gene · 1287
Papers2,056
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,056
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A founder COL4A3 pathogenic variant resulting in Alport syndrome and thin basement membrane disease: a case report series. | Front Med (Lausanne) | 2023 | 38188341 | PubTator, text mining | PubMed |
| A novel ADAMTSL4 compound heterozygous mutation in isolated ectopia lentis: a case report and review of the literature. | J Med Case Rep | 2023 | 38146062 | PubTator, text mining | PubMed |
| Phenotype-Genotype Correlations in Three Different Cases of Adult-Onset Genetic Focal Segmental Glomerulosclerosis. | Int J Mol Sci | 2023 | 38139322 | PubTator, text mining | PubMed |
| Modulation of miR-29 influences myocardial compliance likely through coordinated regulation of calcium handling and extracellular matrix. | Mol Ther Nucleic Acids | 2023 | 38111915 | PubTator, text mining | PubMed |
| Polygenic risk alters the penetrance of monogenic kidney disease. | Nat Commun | 2023 | 38097619 | PubTator, text mining | PubMed |
| Synergistic Inhibitory Effect of Berberine and Low-Temperature Plasma on Non-Small-Cell Lung Cancer Cells via PI3K-AKT-Driven Signaling Axis. | Molecules | 2023 | 38067530 | PubTator, text mining | PubMed |
| Sensorineural Hearing Loss in Patients With Chronic Kidney Disease: A Comprehensive Review. | Cureus | 2023 | 38054127 | PubTator, text mining | PubMed |
| Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis. | Front Oncol | 2023 | 38045004 | PubTator, text mining | PubMed |
| Ataxia Syndrome With Hearing Loss and Nephronophthisis Associated With a Novel Homozygous Variant in XPNPEP3. | Neurol Genet | 2023 | 38035175 | PubTator, text mining | PubMed |
| Post-coronavirus disease 2019 functional impairments, limitations, and restrictions: A prospective cohort study based on the international classification of functioning, disability, and health. | J Cent Nerv Syst Dis | 2023 | 38025402 | PubTator, text mining | PubMed |
| Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma. | Front Oncol | 2023 | 38023248 | PubTator, text mining | PubMed |
| Alport Syndrome: A Comprehensive Review. | Cureus | 2023 | 38021591 | PubTator, text mining | PubMed |
| Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. | BMC Cancer | 2023 | 38017425 | PubTator, text mining | PubMed |
| Novel Approaches to Possible Targeted Therapies and Prophylaxis of Uterine Fibroids. | Diseases | 2023 | 37987267 | PubTator, text mining | PubMed |
| Pregnancy in women with autosomal recessive Alport syndrome caused by novel compound heterozygous mutations of COL4A3 gene: Two cases reports. | Medicine (Baltimore) | 2023 | 37986374 | PubTator, text mining | PubMed |
| Advancements in the Genetics of Spontaneous Coronary Artery Dissection. | Curr Cardiol Rep | 2023 | 37979122 | PubTator, text mining | PubMed |
| Collagen IV of basement membranes: II. Emergence of collagen IVα345 enabled the assembly of a compact GBM as an ultrafilter in mammalian kidneys. | J Biol Chem | 2023 | 37977222 | PubTator, text mining | PubMed |
| High-flow arteriovenous fistula in X-linked Alport syndrome: a case report. | Front Med (Lausanne) | 2023 | 37928459 | PubTator, text mining | PubMed |
| Comprehensive analysis of the relationship between xanthine oxidoreductase activity and chronic kidney disease. | iScience | 2023 | 37927553 | PubTator, text mining | PubMed |
| Genetic testing in focal segmental glomerulosclerosis: in whom and when? | Clin Kidney J | 2023 | 37915894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1287/papers?page=12